Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

for
Childhood Langerhans Cell Histiocytosis, Fanconi Anemia,
Location: Hershey PA
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 21

Code: NCT00084695

Phase 2, Recruiting

Medical Imaging and Focused Ultrasound Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)

for
Fibroadenoma, Breast Cancer Stage I
Location: New York NY
Sponsor: Columbia University

Sex: Female

Age: 18+

Code: NCT05219695

Phase 1, Recruiting

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

for
Advanced/Metastatic Solid Tumors
Location: Cleveland OH, Houston TX, Scottsdale AZ, Seattle WA,
Sponsor: Adagene Inc

Sex: All

Age: 18+

Code: NCT05405595

Phase 1, Phase 2, Recruiting

Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor

for
Advanced Breast Cancer
Location: Lebanon NH
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: Female

Age: 18+

Code: NCT05933395

Phase 2, Recruiting

Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors

for
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer,
Location: Fairfax VA, Durham NC, Charlotte NC, Canton OH,
Sponsor: Sairopa B.V.

Sex: All

Age: 18+

Code: NCT05856981

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care

for
Cancer, Heart Failure, Copd, ALS
Location: Winnipeg
Sponsor: Riverview Health Centre

Sex: All

Age: 0+

Code: NCT04138095

Recruiting

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

for
Cancer Related Cognitive Difficulties, Breast Cancer Female
Location: Rochester NY
Sponsor: University of Rochester

Sex: Female

Age: 21+

Code: NCT03137095

Recruiting

HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors

for
Solid Tumors, Adult
Location: Dallas TX
Sponsor: HighField Biopharmaceuticals Corporation

Sex: All

Age: 18 - 70+

Code: NCT05861895

Phase 1, Recruiting

Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients

for
Granulocyte Colony-Stimulating Factor,
Location: Jackson MS
Sponsor: University of Mississippi Medical Center

Sex: All

Age: 0 - 21

Code: NCT03823950

Recruiting

Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

for
Breast Neoplasm
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: Female

Age: 18+

Code: NCT06058650

Recruiting

Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer

for
Breast Cancer, Cervical Cancer, Endometrial Cancer,
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: Female

Age: 18+

Code: NCT00003135

Phase 2, Recruiting

Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers

for
Metastatic Cancers, Fatigue
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06085716

Phase 2, Phase 3, Recruiting

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

for
Breast Neoplasm Female, Radiotherapy, Cosmetic Outcome
Location: Halifax, Quebec, Sherbrooke, Trois-Rivieres,
Sponsor: Ontario Clinical Oncology Group (OCOG)

Sex: Female

Age: 50 - 70+

Code: NCT05417516

Phase 3, Recruiting

Molecular Analysis Of Solid Tumors

for
Pediatric Solid Tumors
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 25

Code: NCT01050296

Recruiting

Survivorship Plan HEalth REcord (SPHERE) Implementation Trial

for
Cancer
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18 - 70+

Code: NCT05346796

Recruiting

An Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced Tumors

for
Advanced Solid Tumor, Refractory Hodgkin Lymphoma
Location: Greenville SC
Sponsor: FBD Biologics Limited

Sex: All

Age: 18+

Code: NCT06487624

Phase 1, Recruiting

UNC Metastatic Cancer Radiation Therapy Registry

for
Cancer, Metastatic Cancer
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06306924

Recruiting

Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis

for
Breast Cancer
Location: Hamilton
Sponsor: Juravinski Cancer Center

Sex: All

Age: 18+

Code: NCT03295916

Early Phase 1, Recruiting

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

for
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Location: Boston MA, New York NY, Philadelphia PA, Miami FL,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT03686124

Phase 1, Phase 2, Recruiting

Collection of Blood From Patients With Cancer

for
Prostate Cancer, Breast Cancer, Colon Cancer, Lung Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT00034216

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial